Syntone Ventures Llc Outlook Therapeutics, Inc. (OTLK) insider trading activity

OTLK Quotes by TradingView

Syntone Ventures LLC is of Outlook Therapeutics, Inc.. Currently has a direct ownership of 1.71 Million shares of OTLK, which is worth approximately $8.58 Million. The most recent transaction as insider was on Apr 15, 2024, when has been sold 714,286 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.71M
0% 3M change
91.4% 12M change
Total Value Held $8.58 Million

Syntone Ventures LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 15 2024
BUY
Open market or private purchase
-
714,286 Added 29.52%
1,705,438 Common Stock
Feb 03 2021
BUY
Open market or private purchase
$3,000,000 $1.0 p/Share
3,000,000 Added 13.14%
19,823,045 Common Stock
SVL

Syntone Ventures LLC

Cary, NC

Track Institutional and Insider Activities on OTLK

Follow Outlook Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OTLK shares.

Notify only if

Insider Trading

Get notified when an Outlook Therapeutics, Inc. insider buys or sells OTLK shares.

Notify only if

News

Receive news related to Outlook Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OTLK